CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer
Authors
A Leo Di
Alvaro Moreno-Aspitia
+43 more
AM Storniolo
Amylou C. Dueck
Ann E. McCullough
C Dang
C Wright
CC Benz
D Slamon
David Johnson
DJ Slamon
Donald Northfelt
EA Perez
EA Perez
EA Perez
EA Perez
Edith A. Perez
EH Romond
FJ Esteva
Frances M. Palmieri
GE Konecny
Gerardo Colon-Otero
H Joensuu
H Yaziji
Ismael Ghanem-Cañete
J Baselga
J Crown
J Winstanley
JR Ross
JS Ross
Kathleen S. Tenner
KL Blackwell
L Coussens
M Untch
MJ Piccart-Gebhart
MN Levine
MS Ewer
Richard Rodeheffer
Robert B. Jenkins
S Johnston
Sandra Franco
Shaker Dakhil
Stephen Kahanic
Tejal Patel
W Xia
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1007%2Fs10549-013-...
Last time updated on 28/03/2019